NIH drafts policy on ensuring access to new drugs funded by taxpayers
The NIH has proposed requiring biopharma companies or licensees to submit plans for how patients will access drugs or devices that are developed with the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
